524632 — Shukra Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Shukra Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	5.04	0.854	39.7	99.8	121
Net Total Accounts Receivable
Net Total Receivables	132	105	327	268	378
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	161	157	531	562	654
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	194	192	219	216	213
Long Term Investments
Total Assets	356	351	750	778	868
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70.3	124	425	142	173
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	200	188	497	202	239
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	156	164	253	576	628
Total Liabilities & Shareholders' Equity	356	351	750	778	868
Total Common Shares Outstanding